Jefferies Group LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 13 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$57,000
-97.7%
5,715,0000.0%0.00%
-100.0%
Q3 2018$2,500,0000.0%5,715,0000.0%0.02%
+14.3%
Q2 2018$2,500,0000.0%5,715,0000.0%0.01%
+7.7%
Q1 2018$2,500,000
+4.8%
5,715,0000.0%0.01%
+18.2%
Q4 2017$2,386,000
+1.8%
5,715,0000.0%0.01%
-26.7%
Q3 2017$2,343,000
+40.0%
5,715,0000.0%0.02%
+36.4%
Q2 2017$1,674,000
+25.9%
5,715,000
+9.6%
0.01%
+10.0%
Q1 2017$1,330,000
+2.6%
5,215,0000.0%0.01%
+42.9%
Q4 2016$1,296,000
-11.2%
5,215,0000.0%0.01%
-12.5%
Q3 2016$1,459,000
+27.2%
5,215,0000.0%0.01%
+60.0%
Q2 2016$1,147,0005,215,0000.01%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2017
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 2,000,000$36,0000.00%
Bruce & Co., Inc. 2,000,000$10,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders